Teachers Retirement System of The State of Kentucky Acquires New Position in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)

Teachers Retirement System of The State of Kentucky acquired a new stake in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 298,000 shares of the company's stock, valued at approximately $7,420,000. Teachers Retirement System of The State of Kentucky owned approximately 0.05% of Fresenius Medical Care AG & Co. KGaA as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. grew its position in Fresenius Medical Care AG & Co. KGaA by 5.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock valued at $210,000 after purchasing an additional 442 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in Fresenius Medical Care AG & Co. KGaA by 0.9% during the first quarter. Crossmark Global Holdings Inc. now owns 64,871 shares of the company's stock valued at $1,615,000 after purchasing an additional 584 shares in the last quarter. Callan Capital LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 6.6% during the first quarter. Callan Capital LLC now owns 13,974 shares of the company's stock valued at $348,000 after purchasing an additional 870 shares in the last quarter. Wayfinding Financial LLC purchased a new position in Fresenius Medical Care AG & Co. KGaA during the first quarter valued at approximately $25,000. Finally, Spire Wealth Management purchased a new position in Fresenius Medical Care AG & Co. KGaA during the first quarter valued at approximately $27,000. 8.37% of the stock is owned by hedge funds and other institutional investors.

Fresenius Medical Care AG & Co. KGaA Stock Performance

FMS stock opened at $26.30 on Tuesday. The company has a quick ratio of 1.08, a current ratio of 1.46 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $15.43 billion, a price-to-earnings ratio of 23.48, a P/E/G ratio of 0.63 and a beta of 0.87. Fresenius Medical Care AG & Co. KGaA has a 12 month low of $17.93 and a 12 month high of $30.46. The firm has a 50 day moving average of $28.15 and a two-hundred day moving average of $25.53.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.01. The business had revenue of $5.54 billion during the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.18% and a return on equity of 6.25%. As a group, equities analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 EPS for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 23rd were issued a dividend of $0.7871 per share. This is an increase from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.44. This represents a dividend yield of 1.9%. The ex-dividend date was Friday, May 23rd. Fresenius Medical Care AG & Co. KGaA's dividend payout ratio is currently 50.89%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on FMS. Truist Financial boosted their price objective on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $30.00 and gave the company a "hold" rating in a research report on Monday, May 12th. Wall Street Zen raised shares of Fresenius Medical Care AG & Co. KGaA from a "hold" rating to a "strong-buy" rating in a research report on Saturday, July 5th. Finally, Morgan Stanley reissued an "underweight" rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Fresenius Medical Care AG & Co. KGaA has an average rating of "Hold" and an average target price of $27.80.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.